雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床研究
Clinical study of Leizumab injection combined with cataract phacoemulsification in the treatment of cataract complicated with diabetic macular edema
ES评分 0
| DOI |
10.12208/j.ijmd.20240044 |
| 刊名 |
International Journal of Medicine and Data
|
| 年，卷(期) |
2024, 8(3) |
| 作者 |
|
| 作者单位 |
江苏省响水县人民医院眼科 江苏响水 ;
|
| 摘要 |
探究分析雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床效果。方法 时间：2023年1月至2023年12月，对象：白内障合并糖尿病性黄斑水肿患者共40例，分组：随机分为对照组与观察组。对照组白内障超声乳化治疗，观察组采用雷珠单抗注射液联合白内障超声乳化治疗，对比两组最佳矫正视力，黄斑中心视网膜厚度；眼压水平以及并发症发生率。结果 观察组优于对照组，P＜0.05。结论 雷珠单抗注射液联合白内障超声乳化可显著改善患者最佳矫正视力，黄斑中心视网膜厚度；眼压水平，且具有优良的安全性，值得推广与应用。
|
| Abstract |
Objective To explore the clinical effect of lezumab injection combined with phacoemulsification in cataract combined with diabetic macular edema. Methods time: January 2023 to December 2023, target: 40 patients with cataract and diabetic macular edema, group: randomized into control group and observation group. The control group received cataract phacoemulsification, and the observation group used rizumab injection combined with cataract phacoemulsification, comparing the two groups with best corrected visual acuity, central macular retinal thickness; intraocular pressure level and complication rate. Results The observed group was better than the control group with P <0.05. Conclusion Lezumab injection combined with phacoemulsification can significantly improve the best corrected visual acuity, central macular retinal thickness; intraocular pressure level, and has excellent safety.
|
| 关键词 |
白内障；糖尿病性黄斑水肿；雷珠单抗；白内障超声乳化；最佳矫正视力，黄斑中心视网膜厚度；眼压水平；并发症发生率
|
| KeyWord |
Cataract; diabetic macular edema; Rizumab; Phacoemulsification; Best corrected vision, Central macular retinal thickness; Intraocular pressure level; Complication rate
|
| 基金项目 |
|
| 页码 |
83-86 |
周翠平*.
雷珠单抗注射液联合白内障超声乳化治疗白内障合并糖尿病性黄斑水肿的临床研究 [J].
国际医学与数据杂志.
2024; 8; (3).
83 - 86.